Carsyon I E Learning-march

25 Questions | By Microlabs1 | Updated: Mar 22, 2016 | Attempts: 63

Questions

Settings

Feedback

During the Quiz End of Quiz

Play as

Quiz Flashcard

Create your own Quiz

Welcome to March E-Learning TestYou have 20 minutes to complete this test. Please enter your name and Emp. Code and press "Start" to begin the test. You can only attend the test once and hence make sure you are uninterrupted internet connectivity. https://w

Questions and Answers

1.

Upload your response
2.

Upload your response
3.

There is no document available yet, please upload the document
4.

Cardiovascular & Cerebrovascular diseases are the major causes of death contributing to about -----% of total death.
- A.
  
  35
- B.
  
  39
- C.
  
  25
- D.
  
  45
5.

As per Department of food & nutrition, there are -------- existing cases of CHD.
- A.
  
  6.1 million
- B.
  
  61 million
- C.
  
  0.61 million
- D.
  
  1.6 million
6.

Times of India report states that there are ------ stroke cases annually.
- A.
  
  1.6 million
- B.
  
  16 million
- C.
  
  6.1 million
- D.
  
  61 million
7.

Coronary atherosclerotic plaque is formed due to
- A.
  
  Accumulation of proteins
- B.
  
  Accumulation of lipids
- C.
  
  Accumulation of carbohydrates
- D.
  
  Accumulation of antioxidants
8.

Platelet cascade in ACS consists of 4 steps in the following order:
- A.
  
  Adhesion, Aggregation, Platelet plug, Activation.
- B.
  
  Activation, Adhesion, Aggregation, Platelet plug.
- C.
  
  Aggregation, activation, Adhesion, Platelet plug.
- D.
  
  Adhesion, Activation, Aggregation, Platelet Plug.
9.

ACS stands for
- A.
  
  Acute Chronic syndrome
- B.
  
  Acute Coronary syndrome
- C.
  
  Acute Cerebral Syndrome
- D.
  
  Aortic Cardiac syndrome
10.

STEMI stands for
- A.
  
  Soft tissue effect on Myocardial infarction
- B.
  
  Secondary trial effect on Myocardial infarction
- C.
  
  ST segment elevation Myocardial Infarction
- D.
  
  None of the above
11.

Clopidogrel is a
- A.
  
  First gen.thienopyridine
- B.
  
  Second gen.thienopyridine
- C.
  
  Third gen. thienopyridine
- D.
  
  Statin
12.

PCI stands for
- A.
  
  Percutaneous Coronary Intervention
- B.
  
  Persistent Coronary Intervension
- C.
  
  Perennial Coronary Intervention
- D.
  
  None of the above
13.

Clopidogrel provides antiplatelet effect by
- A.
  
  Irreversibly inhibiting platelet COX
- B.
  
  Reversibly inhibiting platelet COX
- C.
  
  Irreversibly and selectively inhibiting ADP induced platelet aggregation mediated by P2Y12 receptor
- D.
  
  None of the above
14.

Avas CV is a combination of
- A.
  
  An antiplatelet and a Statin
- B.
  
  An antiplatelet and a diuretic
- C.
  
  An antiplatelet and an anti hypertensive
- D.
  
  None of the above
15.

Factors that trigger ACS and Stroke are
- A.
  
  Hypertension
- B.
  
  High Cholesterol
- C.
  
  Endothelial dysfunction
- D.
  
  All of the above
16.

CABG stands for
- A.
  
  Clopidogrel and Aspirin in Bypass graft.
- B.
  
  Coronary Artery Bypass graft.
- C.
  
  Cholesterol Activated Bypass Graft
- D.
  
  None of the above
17.

Avas CV is a combination of
- A.
  
  Aspirin and Clopidogrel
- B.
  
  Atorvastatin and Aspirin
- C.
  
  Atorvastatin & Clopidogrel
- D.
  
  Atorvastatin, Aspirin & Clopidogrel.
18.

Avas CV is ideal for
- A.
  
  Protection from secondary CV events
- B.
  
  Protection from hypertension
- C.
  
  Preventing hypertension
- D.
  
  None of the above
19.

Atorvastatin
- A.
  
  Has anti-inflammatory properties
- B.
  
  Does not have anti-inflammatory properties
- C.
  
  Has nothing to do with inflammation
- D.
  
  Causes inflammation
20.

An atherosclerotic plaque is formed in
- A.
  
  Artery
- B.
  
  Platelets
- C.
  
  RBCs
- D.
  
  WBCs
21.

Clopidogrel and Aspirin have
- A.
  
  Same mechanism of action
- B.
  
  Different mechanism of action
- C.
  
  Variable mechanism of action
- D.
  
  None of the above
22.

Avas CV in ACS
- A.
  
  Increases mortality
- B.
  
  Decreases mortality
- C.
  
  Has no effect on mortality
- D.
  
  None of the above
23.

The (CURE) Trial was a comparative study between
- A.
  
  Aspirin alone and combination of Aspirin with Clopidogrel
- B.
  
  Aspirin alone and combination of Aspirin with Atorvastatin
- C.
  
  Aspirin alone and combination of Atorvastatin with Clopidogrel
- D.
  
  Aspirin alone and combination of Clopidogrel with Atorvastatin
24.

The (CURE) trial was conducted on
- A.
  
  2116 patients
- B.
  
  21160 patients
- C.
  
  12562 patients
- D.
  
  125620 patients
25.

The (CREDO) trial confirmed that Clopidogrel reduced the 1-year risk of MI and CVA or death by
- A.
  
  57 %
- B.
  
  27%
- C.
  
  72%
- D.
  
  75%